# Bupivacaine Liposomal Injectable Suspension, Pain and Narcotic Use After Elective Orthognathic Surgery

> **NCT03318757** · PHASE4 · WITHDRAWN · sponsor: **Boston University**

## Conditions studied

- Orthognathic Surgery

## Interventions

- **DRUG:** Bupivacaine Extended Release Liposome Injection
- **DRUG:** Bupivacaine HCl

## Key facts

- **NCT ID:** NCT03318757
- **Lead sponsor:** Boston University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-09
- **Primary completion:** 2021-12
- **Final completion:** 2021-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The research could not be conducted as it was denied by the IRB.
- **Last updated:** 2020-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03318757

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03318757, "Bupivacaine Liposomal Injectable Suspension, Pain and Narcotic Use After Elective Orthognathic Surgery". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03318757. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*